Related Experiment Video

Updated: Sep 2, 2026

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells
12:43

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Published on: January 6, 2014

DNA-based vaccines for the treatment of cancer--an experimental model

E P Cohen1

  • 1Department of Microbiology and Immunology (m/c 790), University of Illinois at Chicago, 835 South Wolcott Avenue, Chicago, IL 60612, USA. EPCohen@UIC.EDU

Trends in Molecular Medicine
|April 5, 2001
PubMed

Insights

This study introduces a novel DNA-based vaccine strategy for cancer immunotherapy. By transferring tumor DNA into immunogenic cells, this approach enhances the immune response against a broad range of tumor antigens, effectively deterring tumor growth in animal models.

Area of Science:

  • Oncology
  • Immunology
  • Biotechnology

Background:

  • Antigenic differences between normal and malignant cells are key to cancer immunotherapy.
  • Tumor heterogeneity necessitates vaccines targeting multiple antigens for efficacy.

Purpose of the Study:

  • To develop a DNA-based vaccine strategy for cancer immunotherapy.
  • To enhance the antigenicity of weak tumor antigens for a stronger immune response.

Main Methods:

  • Transferring patient tumor DNA into a highly immunogenic cell line.
  • Utilizing animal models (melanoma and breast cancer) to test the DNA-based vaccine.

Main Results:

  • Weak tumor antigens became strongly antigenic when expressed by immunogenic cells.
  • DNA-based vaccine immunization deterred tumor growth in animal models.
  • Tumor-bearing mice showed prolonged survival rates.

Conclusions:

  • A DNA-based vaccine approach can overcome tumor heterogeneity by presenting a broad array of antigens.
  • This strategy shows promise for improving the efficacy of cancer immunotherapy by enhancing antigen presentation.

More Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Related Concept Videos

Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...